Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-17

Clinical Trial Update: IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life [NA]

View source ↗

Summary

A clinical trial investigating whether discontinuing premedication for weekly paclitaxel affects quality of life in breast cancer patients; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Charles LeMoyne Hospital | Conditions: Breast Cancer | NA | Status: NOT_YET_RECRUITING